Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÁßÃ߽Űæ°è °áÇÙÁ¾ Central Nervous System Tuberculoma

´ëÇѽŰæ¿Ü°úÇÐȸÁö 1998³â 27±Ç 1È£ p.21 ~ 28
±èÀç¿ë, Àü¹ü¼®,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÀç¿ë (  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ÀÓ»óº´¸®°úÇб³½Ç

Àü¹ü¼® (  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç

Abstract

°á·Ð
ÁßÃß ½Å°æ°è °áÇÙÁ¾Àº ³úÀÚ±â°ø¸í¿µ»ó»ó Ư¡ÀûÀÎ ¼Ò°ßÀÌ ÀÖ´Â °æ¿ì°¡ ¸¹¾Æ ¹æ»ç¼±ÇÐÀûÀ¸
·Î, ¶ÇÇÑ ÀÓ»óÀûÀ¸·Î °áÇÙÁ¾ÀÌ ÀǽɵǸé Áø´ÜÀû ¾à¹°Ä¡·á¸¦ ½ÃÇàÇÏ´Â °ÍÀÌ ÁÁÀº Ä¡·á¹æħÀ¸
·Î »ç·áµÈ´Ù. ±×·¯³ª ³úÁ¾¾ç µî°úÀÇ °¨º°Áø´ÜÀÌ ¾î·Á¿î °æ¿ì´Â Áöü¾øÀÌ Á¶Á÷ÇÐÀû Áø´ÜÀ»
ÇÊ¿ä·Î Çϸç Á¶Á÷ÇÐÀû Áø´Ü½Ã ½ÉÇÑ ³ú¾Ð »ó½Â »óÅ°¡ ¾Æ´Ï¸é Á¤À§Àû ¼ö¼ú ¹æ¹ýÀÌ À§Ä¡³ª Å©
±â¿¡ °ü°è¾øÀÌ ¾È°ÇÇÏ°í Á¤È®ÇÑ ¹æ¹ýÀÌ´Ù. ÀûÀýÇÑ Á¶ÇÕÀÇ ¾à¹° Åõ¿©°¡ °¡Àå Áß¿äÇÑ Ä¡·á ¹æ
¹ýÀ̸ç ÀûÀýÇÑ ±â°£ÀÇ ¾à¹° Ä¡·á½Ã ´ëºÎºÐÀÇ Áõ·Ê¿¡¼­ ¿ÏÀüÈ÷ Ä¡À¯µÇ¾ú´Ù.
#ÃÊ·Ï#
The authors present a retrospective analysis of central nervous system(CNS)
tuberculoma, describing the clinical manifestations, radiological findings, diagnosis,
treatment, and prognosis.
Between February 1984 to December 1996, 22 cases of CNS tuberculoma presenting as
intracranial space occupying lesions were managed at Seoul National University Hospital.
The age of patients ranged from two to 47(mean, 28) years and the male-to-female
ratio was 6 to 16. The diagnosis of CNS tuberculoma was pathologically confirmed in
18 cases, while the remaining four were diagnosed on the basis of clinical manifestations
and radiological findings, The duration of follow-up ranged from 10 months to 7
years(median, 2 years). The results of treatment and prognosis were defined according
to the status of patients on their final visit to the outpatients' clinic.
The symptoms of CNS tuberculoma were seizure(45% of cases), headache(36%), visual
disturbance(18%), and hemiparesis(18%), and in 23 patients(55%), the presence of related
pulmonary tuberculosis was noted. The most common site of CNS tuberculoma was the
frontal lobe; multiple lesions were present in five cases, and brain stem lesions in three.
In 13 cases, CNS tuberculoma was seen as low signal intensity on T2 weighted
magnetic resonance images(MRI). Gadolinium-enhanced T1 weighted MRI showed strong
rim enhancement in ten cases and nodular enhancement in five. as well as characteristic
grape-like conglomerated lesions in six cases. Surgical removal was performed in 13
cases, stereotactic biopsy in two, and biopsy via craniotomy in three, Although
microbiologic study was negative in all 18 cases, diagnosis of CNS tuberculoma was
possible on histological examination. After clinical or surgical diagnosis, a course of
anti-tuberculosis medication was started in all patients. In 18 cases, intracranial lesions
disappeared completely after anti-tuberculosis medication, and during the follow-up
period. there was no evidence of recurrence. In three cases the lesions became smaller
during treatment and symptoms improved. One patients died in spite of medication and
decompressive surgery. Between the group of 13 patients who underwent decompressive
surgery or lesionectomy via craniotomy, and the other group of nine, the outcome of
treatment was not different(p=1,000, Fisher's exact test).
In conclusion, the MRI findings of intracranial CNS tuberculoma are characteristic
MRI findings, In cases of CNS tuberculoma, the treatment of choice is anti-tuberculous
medication after histologic confirmation, though if sufficient clinical data support this
diagnosis, then diagnostic and therapeutic medication without histologic confirmation is
recommanded. Stereotactic biopsy is and ideal method for confirming a pathologic
diagnosis of intracranial CNS tuberculoma, except in the cases in which intracranial
pressure is high.

Å°¿öµå

Tuberculosis; Central nervous system; Magnetic resonace imaging; Stereotactic surgery;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS